Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

Q. I saw the news recently that the Food and Drug Administration is proposing to remove a popular ingredient in ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

Spasmodic dysphonia impacts about 50,000 people in North America. Here's what to know about what causes spasmodic dysphonia ...

LSU Health Shreveport Otolaryngology-Head and Neck Surgery residents earned top honors at The Triological Society’s 2025 ...

By Dr. Priyom Bose, Ph.D. Short-term increase in thyroid cancer diagnoses observed with GLP-1RA initiation, likely driven by ...

A new study links heavy cannabis use to head and neck cancer. Learn about the risks, research findings, and prevention ...

Hearing loss (HL) is associated with depression, but existing datasets are limited by the type of data available for both hearing and mental health conditions. The purpose of this study is to determin ...

When a nosebleed hits, we often go into panic mode. We frantically reach for tissues and may try shoving them up in our ...